- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Acacia Research Corporation (Nasdaq:ACTG)(Nasdaq:CBMX) announced today that its Acacia Technologies group, a leader in technology licensing, has named Marc Frechette and James Trueman as Vice Presidents.
Paul Ryan, Acacia Chairman and CEO, commented, "Mr. Frechette and Mr. Trueman have made many valuable contributions to Acacia since joining us last year. Each of their promotions to Vice President is well deserved."
Mr. Frechette joined Acacia in November 2006. Prior to joining Acacia, he was an associate attorney with Crockett & Crockett and an in-house attorney with Discovision Associates, a patent licensing division of Pioneer Electronics. Prior to becoming an attorney, he was an engineer with Boeing, Ducommun, and Conexant. Mr. Frechette is a registered patent attorney and holds a B.S. in Manufacturing Engineering from Boston University, a J.D. from Whittier Law School and recently earned his M.B.A. from the University of California, Los Angeles.
Mr. Trueman joined Acacia in December 2006. He was formerly a Managing Partner for M1 Partners, an Engagement Manager for McKinsey & Company, and a Product/Business Manager for Oracle Corporation. Mr. Trueman also held the positions of Senior Product Manager for Integrated Decision Systems and CEO of Computer Solutions. Mr. Trueman holds a B.S. degree in Business Administration from the University of California, Berkeley and an M.B.A. from the Wharton School.
About Acacia Research Corporation
Acacia Research Corporation comprises two operating groups, Acacia Technologies group and CombiMatrix group.
The Acacia Technologies group develops, acquires, and licenses patented technologies. Acacia controls 71 patent portfolios covering technologies used in a wide variety of industries including audio/video enhancement & synchronization, broadcast data retrieval, computer memory cache coherency, credit card fraud protection, database management, data encryption & product activation, digital media transmission (DMT®), digital video production, dynamic manufacturing modeling, enhanced Internet navigation, image resolution enhancement, interactive data sharing, interactive television, laptop docking station connectivity, microprocessor enhancement, multi-dimensional bar codes, resource scheduling, spreadsheet automation, and user activated Internet advertising.
The CombiMatrix group is developing a platform technology to rapidly produce customizable arrays, which are semiconductor-based tools for use in identifying and determining the roles of genes, gene mutations and proteins. The CombiMatrix's group's technology has a wide range of potential applications in the areas of genomics, proteomics, biosensors, drug discovery, drug development, diagnostics, combinatorial chemistry, material sciences and nanotechnology.
Acacia Research-Acacia Technologies (Nasdaq: ACTG) and Acacia Research-CombiMatrix (Nasdaq: CBMX) are both classes of common stock issued by Acacia Research Corporation and are intended to reflect the performance of the respective operating groups and are not issued by the operating groups.
Information about the Acacia Technologies group and the CombiMatrix group is available at http://www.acaciaresearch.com .
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
This news release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including the recent economic slowdown affecting technology companies, our ability to successfully develop products, rapid technological change in our markets, changes in demand for our future products, legislative, regulatory and competitive developments and general economic conditions. Our Annual Report on Form 10-K, recent and forthcoming Quarterly Reports on Form 10-Q, recent Current Reports on Forms 8-K and 8-K/A, and other SEC filings discuss some of the important risk factors that may affect our business, results of operations and financial condition. We undertake no obligation to revise or update publicly any forward-looking statements for any reason.
For more information, please click here
Acacia Research Corporation
Rob Stewart, Investor Relations, 949-480-8300
Copyright © Business Wire 2007If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016
Novel Electrode Structure Provides New Promise for Lithium-Sulfur Batteries December 3rd, 2016